Advances in migraine and headache therapy (BJP 75th anniversary).
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Works matching IS 00071188 AND DT 2022 AND VI 179 AND IP 3
Results: 11
1
2
5‐hydroxytryptamine in migraine: The puzzling role of ionotropic 5‐HT<sub>3</sub> receptor in the context of established therapeutic effect of metabotropic 5‐HT<sub>1</sub> subtypes.
- Published in:
- British Journal of Pharmacology, 2022, v. 179, n. 3, p. 400, doi. 10.1111/bph.15710
- Publication type:
- Article
3
Characterisation of agonist signalling profiles and agonist‐dependent antagonism at PACAP‐responsive receptors: Implications for drug discovery.
- Published in:
- British Journal of Pharmacology, 2022, v. 179, n. 3, p. 435, doi. 10.1111/bph.15700
- By:
- Publication type:
- Article
4
The selective 5‐HT<sub>1F</sub> receptor agonist lasmiditan inhibits trigeminal nociceptive processing: Implications for migraine and cluster headache.
- Published in:
- British Journal of Pharmacology, 2022, v. 179, n. 3, p. 358, doi. 10.1111/bph.15699
- By:
- Publication type:
- Article
5
Subtype‐selective positive modulation of K<sub>Ca</sub>2 channels depends on the HA/HB helices.
- Published in:
- British Journal of Pharmacology, 2022, v. 179, n. 3, p. 460, doi. 10.1111/bph.15676
- By:
- Publication type:
- Article
6
Biological and small molecule strategies in migraine therapy with relation to the calcitonin gene‐related peptide family of peptides.
- Published in:
- British Journal of Pharmacology, 2022, v. 179, n. 3, p. 371, doi. 10.1111/bph.15669
- By:
- Publication type:
- Article
7
Neonatal Na<sub>V</sub> 1.5 channels: pharmacological distinctiveness of a cancer-related voltage-gated sodium channel splice variant.
- Published in:
- 2022
- By:
- Publication type:
- journal article
8
Pharmacological characterisation of mouse calcitonin and calcitonin receptor‐like receptors reveals differences compared with human receptors.
- Published in:
- British Journal of Pharmacology, 2022, v. 179, n. 3, p. 416, doi. 10.1111/bph.15628
- By:
- Publication type:
- Article
9
Beyond CGRP: The calcitonin peptide family as targets for migraine and pain.
- Published in:
- British Journal of Pharmacology, 2022, v. 179, n. 3, p. 381, doi. 10.1111/bph.15605
- By:
- Publication type:
- Article
10
CGRP receptor antagonists for migraine. Are they also AMY<sub>1</sub> receptor antagonists?
- Published in:
- British Journal of Pharmacology, 2022, v. 179, n. 3, p. 454, doi. 10.1111/bph.15585
- By:
- Publication type:
- Article
11
Issue Information.
- Published in:
- British Journal of Pharmacology, 2022, v. 179, n. 3, p. 353, doi. 10.1111/bph.15546
- Publication type:
- Article